{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:03:56Z","timestamp":1791947036487,"version":"4.3.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH\/NINDS","award":["R01 NS123431"],"award-info":[{"award-number":["R01 NS123431"]}]},{"name":"NIH\/NINDS","award":["R01 NS123431"],"award-info":[{"award-number":["R01 NS123431"]}]},{"name":"NIH\/NINDS","award":["R01 NS123431"],"award-info":[{"award-number":["R01 NS123431"]}]},{"name":"NIH\/NINDS","award":["R01 NS123431"],"award-info":[{"award-number":["R01 NS123431"]}]},{"name":"NIH\/NINDS","award":["R01 NS123431"],"award-info":[{"award-number":["R01 NS123431"]}]},{"name":"NIH\/NINDS","award":["R01 NS123431"],"award-info":[{"award-number":["R01 NS123431"]}]},{"name":"NIH\/NINDS","award":["R01 NS123431"],"award-info":[{"award-number":["R01 NS123431"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-026-01297-9","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T16:16:43Z","timestamp":1771863403000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antiviral innate immunity induces alpha synuclein phosphorylation at serine129 in neurons independent of aggregation"],"prefix":"10.1038","volume":"12","author":[{"given":"Dustin L.","family":"Heiden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Merrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Rajic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Slater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Mahalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki","family":"Traina-Dorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer N.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie J.","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. David","family":"Beckham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"1297_CR1","doi-asserted-by":"publisher","unstructured":"Burr\u00e9, J. et al. \u0391-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science https:\/\/doi.org\/10.1126\/science.1195227 (2010).","DOI":"10.1126\/science.1195227"},{"key":"1297_CR2","doi-asserted-by":"publisher","unstructured":"Goers, J. et al. Nuclear localization of \u03b1-synuclein and its interaction with histones. Biochemistry https:\/\/doi.org\/10.1021\/bi0341152 (2003).","DOI":"10.1021\/bi0341152"},{"key":"1297_CR3","doi-asserted-by":"publisher","unstructured":"Bartels, T., Choi, J. G. & Selkoe, D. J. \u0391-synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature https:\/\/doi.org\/10.1038\/nature10324 (2011).","DOI":"10.1038\/nature10324"},{"key":"1297_CR4","doi-asserted-by":"publisher","unstructured":"Fauvet, B. et al. \u03b1-synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer. J. Biol. Chem. https:\/\/doi.org\/10.1074\/JBC.M111.318949 (2012).","DOI":"10.1074\/JBC.M111.318949"},{"key":"1297_CR5","doi-asserted-by":"publisher","unstructured":"Spillantini, M. G. et al. \u0391-synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.95.11.6469 (1998).","DOI":"10.1073\/pnas.95.11.6469"},{"key":"1297_CR6","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/jbc.M600933200","volume":"281","author":"JP Anderson","year":"2006","unstructured":"Anderson, J. P. et al. Phosphorylation of Ser-129 is the dominant pathological modification of \u03b1-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem. 281, 29739\u201329752 (2006).","journal-title":"J. Biol. Chem."},{"key":"1297_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-022-00382-6","volume":"8","author":"W Poewe","year":"2022","unstructured":"Poewe, W. et al. Multiple system atrophy. Nat. Rev. Dis. Primer 8, 56 (2022).","journal-title":"Nat. Rev. Dis. Primer"},{"key":"1297_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","volume":"16","author":"S Koga","year":"2021","unstructured":"Koga, S., Sekiya, H., Kondru, N., Ross, O. A. & Dickson, D. W. Neuropathology and molecular diagnosis of Synucleinopathies. Mol. Neurodegener. 16, 83 (2021).","journal-title":"Mol. Neurodegener."},{"key":"1297_CR9","doi-asserted-by":"publisher","unstructured":"Singleton, A. B. et al. \u0391-synuclein locus triplication causes Parkinson\u2019s disease. Science https:\/\/doi.org\/10.1126\/science.1090278 (2003).","DOI":"10.1126\/science.1090278"},{"key":"1297_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10789-6","volume":"12","author":"T Ohgita","year":"2022","unstructured":"Ohgita, T., Namba, N., Kono, H., Shimanouchi, T. & Saito, H. Mechanisms of enhanced aggregation and fibril formation of Parkinson\u2019s disease-related variants of \u03b1-synuclein. Sci. Rep. 12, 6770 (2022).","journal-title":"Sci. Rep."},{"key":"1297_CR11","doi-asserted-by":"publisher","unstructured":"Beach, T. G. et al. Olfactory bulb \u03b1-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-008-0450-7 (2009).","DOI":"10.1007\/s00401-008-0450-7"},{"key":"1297_CR12","doi-asserted-by":"publisher","unstructured":"Koprich, J. B., Reske-Nielsen, C., Mithal, P. & Isacson, O. Neuroinflammation mediated by IL-1\u03b2 increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson\u2019s disease. J. Neuroinflammation https:\/\/doi.org\/10.1186\/1742-2094-5-8 (2008).","DOI":"10.1186\/1742-2094-5-8"},{"key":"1297_CR13","doi-asserted-by":"publisher","unstructured":"Hofer, M., Li, W., Lim, S. L. & Campbell, I. L. The type I interferon-alpha mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor 9. J. Neurosci. https:\/\/doi.org\/10.1523\/jneurosci.3711-09.2010 (2010).","DOI":"10.1523\/jneurosci.3711-09.2010"},{"key":"1297_CR14","doi-asserted-by":"publisher","unstructured":"Cocoros, N. M. et al. Long-term risk of Parkinson disease following influenza and other infections. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2021.3895 (2021).","DOI":"10.1001\/jamaneurol.2021.3895"},{"key":"1297_CR15","doi-asserted-by":"publisher","unstructured":"Levine, K. S. et al. Virus exposure and neurodegenerative disease risk across national biobanks. Neuron https:\/\/doi.org\/10.1016\/j.neuron.2022.12.029 (2023).","DOI":"10.1016\/j.neuron.2022.12.029"},{"key":"1297_CR16","doi-asserted-by":"publisher","unstructured":"Taquet, M., Dercon, Q., Todd, J. A. & Harrison, P. J. The recombinant shingles vaccine is associated with lower risk of dementia. Nat. Netw. Boston https:\/\/doi.org\/10.1038\/s41591-024-03201-5 (2024).","DOI":"10.1038\/s41591-024-03201-5"},{"key":"1297_CR17","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1128\/JVI.02949-15","volume":"90","author":"EL Beatman","year":"2015","unstructured":"Beatman, E. L. et al. Alpha-synuclein expression restricts RNA viral infections in the brain. J. Virol. 90, 2767\u20132782 (2015).","journal-title":"J. Virol."},{"key":"1297_CR18","doi-asserted-by":"publisher","first-page":"e0041824","DOI":"10.1128\/jvi.00418-24","volume":"98","author":"A Gupta","year":"2024","unstructured":"Gupta, A. et al. Alpha-synuclein expression in neurons modulates Japanese encephalitis virus infection. J. Virol. 98, e0041824 (2024).","journal-title":"J. Virol."},{"key":"1297_CR19","doi-asserted-by":"publisher","unstructured":"Bantle, C. M. et al. Infection with mosquito-borne alphavirus induces selective loss of dopaminergic neurons, neuroinflammation and widespread protein aggregation. Npj Park. Dis. https:\/\/doi.org\/10.1038\/s41531-019-0090-8 (2019).","DOI":"10.1038\/s41531-019-0090-8"},{"key":"1297_CR20","doi-asserted-by":"publisher","unstructured":"Segers, K. et al. West Nile virus neuroinvasive disease accelerating probable dementia with Lewy bodies. Alzheimer Dis. Assoc. Disord. https:\/\/doi.org\/10.1097\/WAD.0000000000000405 (2020).","DOI":"10.1097\/WAD.0000000000000405"},{"key":"1297_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/S40475-020-00200-7","author":"AY Vittor","year":"2020","unstructured":"Vittor, A. Y. et al. West Nile virus-induced neurologic sequelae\u2014relationship to neurodegenerative cascades and dementias. Curr. Trop. Med. Rep. https:\/\/doi.org\/10.1007\/S40475-020-00200-7 (2020).","journal-title":"Curr. Trop. Med. Rep."},{"key":"1297_CR22","doi-asserted-by":"publisher","unstructured":"Stolzenberg, E. et al. A role for neuronal alpha-synuclein in gastrointestinal immunity. J. Innate Immun. https:\/\/doi.org\/10.1159\/000477990 (2017).","DOI":"10.1159\/000477990"},{"key":"1297_CR23","doi-asserted-by":"publisher","unstructured":"Manfredsson, F. P. et al. Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology. Neurobiol. Dis. https:\/\/doi.org\/10.1016\/j.nbd.2018.01.008 (2018).","DOI":"10.1016\/j.nbd.2018.01.008"},{"key":"1297_CR24","doi-asserted-by":"publisher","unstructured":"Alam, M. M. et al. Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2021.110090 (2022).","DOI":"10.1016\/j.celrep.2021.110090"},{"key":"1297_CR25","doi-asserted-by":"publisher","unstructured":"Monogue, B. et al. Alpha-synuclein supports type 1 interferon signalling in neurons and brain tissue. Brain https:\/\/doi.org\/10.1093\/brain\/awac192 (2022).","DOI":"10.1093\/brain\/awac192"},{"key":"1297_CR26","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/mt.2010.115","volume":"18","author":"OS Gorbatyuk","year":"2010","unstructured":"Gorbatyuk, O. S. et al. In vivo RNAi-mediated alpha-synuclein silencing induces nigrostriatal degeneration. Mol. Ther. J. Am. Soc. Gene Ther. 18, 1450\u20131457 (2010).","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"1297_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41531-024-00830-y","volume":"10","author":"BG Trist","year":"2024","unstructured":"Trist, B. G. et al. Novel tools to quantify total, phospho-Ser129 and aggregated alpha-synuclein in the mouse brain. Npj Park. Dis. 10, 217 (2024).","journal-title":"Npj Park. Dis."},{"key":"1297_CR28","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/nprot.2014.143","volume":"9","author":"LA Volpicelli-Daley","year":"2014","unstructured":"Volpicelli-Daley, L. A. Volpicelli-Daley et al. Addition of exogenous \u03b1-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous \u03b1-synuclein to Lewy body and Lewy neurite-like aggregates. Nat. Protoc. 9, 2135\u20132146 (2014).","journal-title":"Nat. Protoc."},{"key":"1297_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.nbd.2015.06.003","volume":"82","author":"KL Paumier","year":"2015","unstructured":"Paumier, K. L. et al. Intrastriatal injection of pre-formed mouse \u03b1-synuclein fibrils into rats triggers \u03b1-synuclein pathology and bilateral nigrostriatal degeneration. Neurobiol. Dis. 82, 185\u2013199 (2015).","journal-title":"Neurobiol. Dis."},{"key":"1297_CR30","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41577-020-0288-3","volume":"20","author":"J Rehwinkel","year":"2020","unstructured":"Rehwinkel, J. & Gack, M. U. RIG-I-like receptors: their regulation and roles in RNA sensing. Nat. Rev. Immunol. 20, 537\u2013551 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1297_CR31","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.brainres.2014.05.049","volume":"1574","author":"AH Sabouri","year":"2014","unstructured":"Sabouri, A. H. et al. TLR signaling controls lethal encephalitis in WNV-infected brain. Brain Res 1574, 84\u201395 (2014).","journal-title":"Brain Res"},{"key":"1297_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1749-6632.2000.tb06900.x","volume":"920","author":"MG Spillantini","year":"2000","unstructured":"Spillantini, M. G. & Goedert, M. The alpha-synucleinopathies: Parkinson\u2019s disease, dementia with Lewy bodies, and multiple system atrophy. Ann. N. Y. Acad. Sci. 920, 16\u201327 (2000).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1297_CR33","doi-asserted-by":"publisher","unstructured":"Raquel, P. et al. Nuclear localization and phosphorylation modulate pathological effects of Alpha-Synuclein. Hum. Mol. Genet. https:\/\/doi.org\/10.1093\/hmg\/ddy326 (2019).","DOI":"10.1093\/hmg\/ddy326"},{"key":"1297_CR34","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","volume":"25","author":"A Abeliovich","year":"2000","unstructured":"Abeliovich, A. et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25, 239\u2013252 (2000).","journal-title":"Neuron"},{"key":"1297_CR35","doi-asserted-by":"publisher","first-page":"E4274","DOI":"10.1073\/pnas.1416598111","volume":"111","author":"J Burr\u00e9","year":"2014","unstructured":"Burr\u00e9, J., Sharma, M. & S\u00fcdhof, T. C. \u03b1-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation. Proc. Natl. Acad. Sci. USA. 111, E4274\u2013E4283 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"1297_CR36","doi-asserted-by":"publisher","unstructured":"Marreiros, R. et al. Disruption of cellular proteostasis by H1N1 influenza A virus causes \u03b1-synuclein aggregation. Proc. Natl. Acad. Sci. USA. https:\/\/doi.org\/10.1073\/pnas.1906466117 (2020).","DOI":"10.1073\/pnas.1906466117"},{"key":"1297_CR37","doi-asserted-by":"publisher","unstructured":"Jang, H. et al. Inflammatory effects of highly pathogenic H5N1 influenza virus infection in the CNS of mice. J. Neurosci. https:\/\/doi.org\/10.1523\/jneurosci.5123-11.2012 (2012).","DOI":"10.1523\/jneurosci.5123-11.2012"},{"key":"1297_CR38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bbi.2025.05.021","volume":"129","author":"CS Schreiber","year":"2025","unstructured":"Schreiber, C. S. et al. Intravenous SARS-CoV-2 spike protein induces neuroinflammation and alpha-Synuclein accumulation in brain regions relevant to Parkinson\u2019s disease. Brain. Behav. Immun. 129, 102\u2013123 (2025).","journal-title":"Brain. Behav. Immun."},{"key":"1297_CR39","doi-asserted-by":"publisher","unstructured":"Ma, M. R. et al. Phosphorylation induces distinct alpha-synuclein strain formation. Sci. Rep. https:\/\/doi.org\/10.1038\/srep37130 (2016).","DOI":"10.1038\/srep37130"},{"key":"1297_CR40","doi-asserted-by":"publisher","unstructured":"Gorbatyuk, O. S. et al. The phosphorylation state of Ser-129 in human \u03b1-synuclein determines neurodegeneration in a rat model of Parkinson disease. Proc. Natl. Acad. Sci. USA. https:\/\/doi.org\/10.1073\/pnas.0711053105 (2008).","DOI":"10.1073\/pnas.0711053105"},{"key":"1297_CR41","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/jbc.M600933200","volume":"281","author":"JP Anderson","year":"2006","unstructured":"Anderson, J. P. et al. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem. 281, 29739\u201329752 (2006).","journal-title":"J. Biol. Chem."},{"key":"1297_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/13550280590900454","volume":"11","author":"E Hunsperger","year":"2005","unstructured":"Hunsperger, E. & Roehrig, J. T. Characterization of West Nile viral replication and maturation in peripheral neurons in culture. J. Neurovirol. 11, 11\u201322 (2005).","journal-title":"J. Neurovirol."},{"key":"1297_CR43","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4161\/auto.19371","volume":"8","author":"J Klucken","year":"2012","unstructured":"Klucken, J. et al. Alpha-synuclein aggregation involves a bafilomycin A 1-sensitive autophagy pathway. Autophagy 8, 754\u2013766 (2012).","journal-title":"Autophagy"},{"key":"1297_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0252-8","volume":"9","author":"S Thellung","year":"2018","unstructured":"Thellung, S. et al. Pharmacological activation of autophagy favors the clearing of intracellular aggregates of misfolded prion protein peptide to prevent neuronal death. Cell Death Dis 9, 166 (2018).","journal-title":"Cell Death Dis"},{"key":"1297_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06251-8","volume":"14","author":"O Lurette","year":"2023","unstructured":"Lurette, O. et al. Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization. Cell Death Dis 14, 729 (2023).","journal-title":"Cell Death Dis"},{"key":"1297_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13024-020-00368-6","volume":"15","author":"BA Hijaz","year":"2020","unstructured":"Hijaz, B. A. & Volpicelli-Daley, L. A. Initiation and propagation of \u03b1-synuclein aggregation in the nervous system. Mol. Neurodegener. 15, 19 (2020).","journal-title":"Mol. Neurodegener."},{"key":"1297_CR47","doi-asserted-by":"publisher","unstructured":"Song, E. et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20202135 (2021).","DOI":"10.1084\/jem.20202135"},{"key":"1297_CR48","doi-asserted-by":"publisher","unstructured":"Brann, D. H. et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci. Adv. https:\/\/doi.org\/10.1126\/sciadv.abc5801 (2020).","DOI":"10.1126\/sciadv.abc5801"},{"key":"1297_CR49","unstructured":"Bayati, A. et al. Modeling Parkinson\u2019s disease pathology in human dopaminergic neurons by sequential exposure to \u03b1-synuclein fibrils and proinflammatory cytokines. Nat. Neurosci. https:\/\/www.nature.com\/articles\/s41593-024-01775-4."},{"key":"1297_CR50","doi-asserted-by":"publisher","unstructured":"Hofer, M. J., Li, W., Lim, S. L. & Campbell, I. L. The type I interferon-\u03b1 mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor 9. J. Neurosci. https:\/\/doi.org\/10.1523\/JNEUROSCI.3711-09.2010 (2010).","DOI":"10.1523\/JNEUROSCI.3711-09.2010"},{"key":"1297_CR51","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/glia.23028","volume":"64","author":"BS Main","year":"2016","unstructured":"Main, B. S. et al. Type-1 interferons contribute to the neuroinflammatory response and disease progression of the MPTP mouse model of Parkinson\u2019s disease. Glia 64, 1590\u20131604 (2016).","journal-title":"Glia"},{"key":"1297_CR52","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2015.08.069","volume":"163","author":"P Ejlerskov","year":"2015","unstructured":"Ejlerskov, P. et al. Lack of neuronal IFN-\u03b2-IFNAR causes Lewy body- and Parkinson\u2019s disease-like dementia. Cell 163, 324\u2013339 (2015).","journal-title":"Cell"},{"key":"1297_CR53","doi-asserted-by":"publisher","first-page":"e57145","DOI":"10.15252\/embr.202357145","volume":"24","author":"N Ramalingam","year":"2023","unstructured":"Ramalingam, N., Brontesi, L., Jin, S., Selkoe, D. J. & Dettmer, U. Dynamic reversibility of \u03b1-synuclein serine-129 phosphorylation is impaired in synucleinopathy models. EMBO Rep 24, e57145 (2023).","journal-title":"EMBO Rep"},{"key":"1297_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24867-2","volume":"12","author":"K Wang","year":"2021","unstructured":"Wang, K. et al. STING suppresses bone cancer pain via immune and neuronal modulation. Nat. Commun. 12, 4558 (2021).","journal-title":"Nat. Commun."},{"key":"1297_CR55","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41586-020-03151-1","volume":"591","author":"CR Donnelly","year":"2021","unstructured":"Donnelly, C. R. et al. STING controls nociception via type I interferon signalling in sensory neurons. Nature 591, 275\u2013280 (2021).","journal-title":"Nature"},{"key":"1297_CR56","doi-asserted-by":"crossref","unstructured":"Franco-Enz\u00e1stiga, \u00da. et al. Type I IFNs enhance human dorsal root ganglion nociceptor excitability and induce TRPV1 sensitization. JCI Insight 10, e194987 (2025).","DOI":"10.1172\/jci.insight.194987"},{"key":"1297_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2023.11.020","author":"LA Parra-Rivas","year":"2023","unstructured":"Parra-Rivas, L. A. et al. Serine-129 phosphorylation of \u03b1-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function. Neuron https:\/\/doi.org\/10.1016\/j.neuron.2023.11.020 (2023).","journal-title":"Neuron"},{"key":"1297_CR58","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101\u20131108 (2008).","journal-title":"Nat. Protoc."},{"key":"1297_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/SREP14211","author":"A Sasaki","year":"2015","unstructured":"Sasaki, A., Arawaka, S., Sato, H. & Kato, T. Sensitive western blotting for detection of endogenous Ser129-phosphorylated \u03b1-synuclein in intracellular and extracellular spaces. Sci. Rep. https:\/\/doi.org\/10.1038\/SREP14211 (2015).","journal-title":"Sci. Rep."},{"key":"1297_CR60","doi-asserted-by":"publisher","first-page":"100372","DOI":"10.1016\/j.xpro.2021.100372","volume":"2","author":"I Stojkovska","year":"2021","unstructured":"Stojkovska, I. & Mazzulli, J. R. Detection of pathological alpha-synuclein aggregates in human iPSC-derived neurons and tissue. STAR Protoc 2, 100372 (2021).","journal-title":"STAR Protoc"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01297-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01297-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01297-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:21:03Z","timestamp":1774984863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01297-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1297"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01297-9","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}